Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $45.0900 (-2.53%) ($45.0900 - $45.0900) on Tue. Mar. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.93% (three month average) | RSI | 40 | Latest Price | $45.0900(-2.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.9% a day on average for past five trading days. | Weekly Trend | HALO declines -2.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.465% in a week (0% probabilities). VIXM(-31%) VXX(-13%) UUP(-13%) IGOV(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.465% (StdDev 2.93%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $48.57 | 5 Day Moving Average | $47.26(-4.59%) | 10 Day Moving Average | $47.86(-5.79%) | 20 Day Moving Average | $48.57(-7.16%) | To recent high | -13.2% | To recent low | 15.2% | Market Cap | $6.163b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |